Ranging from irritating to debilitating, joint pain can be tricky to treat. If your pain is mild, ibuprofen or acetaminophen might be adequate. But the worse it gets, the more likely you are to be prescribed antidepressants, muscle relaxants, or even opioids. Because of the side effects associated with these prescription medications, there has been quite a bit of research on CBD and joint pain — with promising results. Here are a few studies that point to CBD’s potential:
Your product is not generally recognized as safe and effective for the referenced uses and, therefore, the product is a “new drug” under section 201(p) of the Act [21 U.S.C. § 321(p)]. New drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from the FDA, as described in section 505(a) of the Act [21 U.S.C. § 355(a)]; see also section 301(d) of the Act [21 U.S.C. § 331(d)]. FDA approves a new drug on the basis of scientific data submitted by a drug sponsor to demonstrate that the drug is safe and effective.
As of May 2017, however, you will find the addition of "Marihuana Extract" in the Texas Register [PDF] (not the Health and Safety Code) by the order [PDF] of the Commissioner of the Department of State Health Services. That order is what the Tarrant County District Attorney is using as a basis to prosecute CBD oil possession cases at the misdemeanor level.
In 2018, The Food and Drug Administration (FDA) approved the first CBD-based medication after years of research suggesting that CBD is beneficial to treat two rare and severe forms of childhood epilepsy. The FDA Commissioner Scott Gottlieb has said the approval was “a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies.” He noted that the action was “not an approval of marijuana or all of its components” but rather of one specific CBD medication for a particular use. In April, an advisory committee unanimously recommended approval of the drug for the two types of epilepsy. FDA CBD rules approving hemp as medicine have helped spread awareness about CBD and acceptance regarding its use.
Success stories like Oliver’s are everywhere, but there’s not a lot of data to back up those results. That’s because CBD comes from cannabis and, like nearly all other parts of the plant, is categorized by the Drug Enforcement Agency (DEA) as a Schedule 1 drug—the most restrictive classification. (Others on that list: heroin, Ecstasy, and peyote.) This classification, which cannabis advocates have tried for years to change, keeps cannabis-derived products, including CBD, from being properly studied in the U.S.
The interest and preference for botanical remedies such as CBD oil over harsh pharmaceuticals are growing rapidly. You can read scientific research on the promise of CBD Oil at NCBI. While North America is taking the lead legalizing cannabis and hemp the rest of the world is starting to question their stance on prohibition because of the undeniable benefits. While all talk about plant-based remedies may seem very new, using cannabis/hemp tinctures as a holistic remedy is a generations-old tradition. It was very common to use tinctures of cannabis oil in the eighteenth and nineteenth centuries. We are enjoying a renaissance in ancestral health where we are open again to remedies that were all but forgotten about in the mad race to make medicines a pill offered by a faceless often unaccountable corporation.
The information above and any other communication regarding legality which you may receive from any representative of Green Roads or the Green Roads’ website is for informational purposes only and not for the purpose of providing legal advice. You must make your own judgment regarding whether you should purchase CBD in your jurisdiction. You should contact your attorney to obtain more specific guidance.*
In 2014, President Obama signed into law the Agricultural Act of 2014. Section 7606 of the act, Legitimacy of Industrial Hemp Research, defines industrial hemp as distinct from marijuana. This authorizes institutions of higher education or state department’s of agriculture in states that legalized hemp cultivation to regulate and conduct research and pilot programs. Basically, it’s up to the states to regulate the growth per their own State Departments.